Delcath Systems Inc (DCTH) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Delcath Systems Inc   (NASDAQ: DCTH)


Delcath Systems Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Delcath Systems Inc's ROI in the third quarter of 2026?
Delcath Systems Inc achieved a return on average invested assets (ROI) of 5.47 % in its third quarter of 2026, this is above DCTH's average return on investment of -535.55%.
Delcath Systems Inc invested over the 12 months ending in its third quarter of 2026 $122 million

ROI has improved compared to 0.46% in the second quarter of 2026, due to net income growth.

Within the Healthcare sector 184 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 2420 to 2433.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 29.96 % 74.74 % 148.02 % 245.29 % 408.46 %
Y / Y Net Income Change TTM 455.43 % -76.16 % - - -35.73 %
Investment (TTM) in Millions 136 124 114 113 116
Return On Investment (TTM) 5.47 % 0.46 % 0.5 % 2.58 % 1.28 %
DCTH's Overall Ranking # 2433 # 2420 # 2474 # 935 #
Seq. Investment Change TTM 4.21 % 3.82 % 7.68 % 11.55 % 40.12 %
Seq. Net Income Change TTM 1150.75 % -5.17 % -79.22 % 125.38 % -46.33 %
Net Income (TTM) in Millions 7 1 1 3 1

DCTH Company Profile >> Back to DCTH Roi Comparisons >> See Annual DCTH Return On Investment



Return On Investment DCTH's Ranking
Within: No.
Industry # 63
Sector # 185
Overall # 2433

Return On Investment Statistics
High Average Low
3.29 %
-535.55 %
-17203.81 %
  (Dec 31 2017)



  News about Delcath Systems Inc Return on Investment ROI

Delcath Systems Strengthens Leadership with Appointment of Martha S. Rook as Chief Operating Officer

March 18, 2024

Delcath Systems Announces Martha S. Rook as New Chief Operating Officer
NEW YORK, March 18, 2024 - Delcath Systems, Inc., a leading interventional oncology company specializing in the treatment of primary and metastatic cancers of the liver, has recently appointed Martha S. Rook as its new Chief Operating Officer (COO). This strategic move is expected to bolster Delcath s operations and provide further momentum for the company as it continues to advance innovative liver cancer treatments.
Martha S. Rook brings a wealth of experience to Delcath Systems, with an impressive track record in the healthcare and pharmaceutical industries. She has held numerous leadership positions, most recently serving as the Vice President of Operations at a prominent oncology therapeutics company. Rook s expertise lies in operational excellence, streamlining processes, and driving business growth. By leveraging her extensive skill set, Delcath aims to enhance its operational efficiency and overall performance.





Financial Statements
Delcath Systems Inc's III. Quarter Investments $ 136 Millions DCTH's Balance sheet
Delcath Systems Inc's III. Quarter Income $ 7 Millions Quarterly DCTH's Income Statement
DCTH's Income by Division See DCTH's Income by Division


DCTH Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 112 70 22 3 27
Y / Y Investment Growth 60.9 % 213.61 % 608.83 % -88.4 % 11.65 %
Net Income in Millions 3 -26 -48 -37 -26
Y / Y Net Income Growth - - - - -
Annual Return On Investment 2.41 % -37.96 % -215.1 % -1167.51 % -95.13 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 2.41 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
DCTH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for DCTH's Competitors
Subscribers only: Roi for Delcath Systems Inc's Suppliers
Subscribers only: Return On Investment for DCTH's Customers

Other Ratios
DCTH's Roa DCTH's Inventory Turnover Ratio DCTH's Growth Rates DCTH's Dividend Statistics
DCTH's Profitability Ratios DCTH's Asset Turnover Ratio DCTH's Dividend Growth
DCTH's Roe DCTH's Valuation Ratios DCTH's Financial Strength Ratios DCTH's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %
Inspire Medical Systems inc   11.63 %
Transmedics Group Inc   11.55 %
Bioventus Inc   11.26 %
Tenet Healthcare Corp  10.91 %
Bio rad Laboratories Inc   10.59 %
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Merit Medical Systems Inc  6.21 %

Date modified: 2026-11-10T09:59:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.